Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular TachycardiaÁngel Arenal, Antonio Berruezo, José Luís Merino et al.|Journal of the American College of Cardiology|2022Cited by 175
Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytesJosé Alberto Navarro‐García, Gema Ruiz‐Hurtado, Carmen Delgado et al.|Nephrology Dialysis Transplantation|2018Cited by 52
The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23José Alberto Navarro‐García, Rafael Salguero‐Bodes, Laura González‐Lafuente et al.|BMC Medicine|2022Cited by 21
P3494Fibroblast growth factor (FGF)-23 induces ventricular arrhytmogenesis through Ca2+ handling dysregulationJosé Alberto Navarro‐García, Gema Ruiz‐Hurtado, Carmen Delgado et al.|European Heart Journal|2017Cited by 0